Carlsbad-based GenMark Diagnostics, a developer of molecular diagnostic testing systems, said this morning that it has acquired a non-exclusive license to technology from Innogentics. The firm said the licesne covers Innogenetics' Hepatitis C Virus (HCV) genotyping patent estate for the United States. Financial details of the license were not disclosed. The move adds testing capability for Hepatitis C (HCV) to the firm's roster of molecular diagnostics offerings.